UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Olanzapine and haloperidol in first episode psychosis: Two-year data

Schizophrenia research, 2006-09, Vol.86 (1), p.234-243

2006

Volltextzugriff (PDF)

Neuropsychological status of subjects at high risk for a first episode of psychosis

Schizophrenia research, 2004-04, Vol.67 (2), p.115-122

2004

Volltextzugriff (PDF)

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

Schizophrenia research, 2021-01, Vol.227, p.28-37

2021

Volltextzugriff (PDF)

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

Schizophrenia research, 2008, Vol.102 (1), p.24-24

2008

Volltextzugriff (PDF)

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics

Molecular psychiatry, 2011-01, Vol.16 (1), p.76-85

2011

Volltextzugriff (PDF)

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning

Schizophrenia research, 2019-06, Vol.208, p.390-396

2019

Volltextzugriff (PDF)

Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis

Behavioural and cognitive psychotherapy, 2020-03, Vol.48 (2), p.248-252

2020

Volltextzugriff (PDF)

Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia

Early intervention in psychiatry, 2015-10, Vol.9 (5), p.397-405

2015

Volltextzugriff (PDF)

The Early Psychosis Screener (EPS): Item development and qualitative validation

Schizophrenia research, 2018-07, Vol.197, p.504-508

2018

Volltextzugriff (PDF)

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning

Schizophrenia research, 2018-07, Vol.197, p.516-521

2018

Volltextzugriff (PDF)

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

Schizophrenia research, 2019-02, Vol.204, p.334-336

2019

Volltextzugriff (PDF)

Computational fluid dynamics modeling aiding surgical planning in a toddler with Parkes Weber syndrome

Journal of pediatric surgery case reports, 2021-03, Vol.66, p.101780, Article 101780

2021

Volltextzugriff (PDF)

Factorial structure of the Scale of Prodromal Symptoms

Schizophrenia research, 2004-06, Vol.68 (2), p.339-347

2004

Volltextzugriff (PDF)

0394 CLINICAL EFFECTIVENESS AND PREDICTORS OF TREATMENT NON-ADHERENCE: COMPARISON OF OLANZAPINE, QUETIAPINE, AND RISPERIDONE IN FIRST-EPISODE PSYCHOSIS

Schizophrenia research, 2006-10, Vol.86, p.S130-S130

2006

Volltextzugriff (PDF)

TC18C MRI OF BRAIN VOLUMES AT THE PRODROME AND FIRST EPISODE STAGES OF SCHIZOPHRENIA

Schizophrenia research, 2006-10, Vol.86, p.S59-S59

2006

Volltextzugriff (PDF)

P.3.c.054 Olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: effectiveness and factors influencing adherence to treatment

European neuropsychopharmacology, 2006, Vol.16, p.S425-S426

2006

Volltextzugriff (PDF)

TC3A EXCESSIVE TOP-DOWN PERCEPTUAL PROCESSING AND REDUCED REAL-WORLD INVESTMENT EXHIBITED BY PRODROMAL PATIENTS PREDICT SUBSEQUENT CONVERSION TO SCHIZOPHRENIA

Schizophrenia research, 2006-10, Vol.86, p.S46-S46

2006

Volltextzugriff (PDF)

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

Schizophrenia research, 2006-10, Vol.86, p.S17-S17

2006

Volltextzugriff (PDF)

WC8B NEUROCOGNITIVE FUNCTIONING IN THE PRODROME TO PSYCHOSIS FROM THE NAPLS COLLABORATION

Schizophrenia research, 2006-10, Vol.86, p.S17-S17

2006

Volltextzugriff (PDF)

S.14.04 CATIE trial results

European neuropsychopharmacology, 2006, Vol.16, p.S184-S185

2006

Volltextzugriff (PDF)

Investigation of olanzapine-associated weight gain in first episode subjects

Schizophrenia research, 2003-03, Vol.60 (1), p.355-356

2003

Volltextzugriff (PDF)

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Schizophrenia research, 2003-03, Vol.60 (1), p.295-295

2003

Volltextzugriff (PDF)

Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders

Schizophrenia research, 2003-03, Vol.60 (1), p.24-24

2003

Volltextzugriff (PDF)

Clinical correlates of weight gain in first episode psychosis patients treated with olanzapine

Schizophrenia research, 2003-03, Vol.60 (1), p.372-372

2003

Volltextzugriff (PDF)

Olanzapine versus placebo for prodromal symptoms

Schizophrenia research, 2003-03, Vol.60 (1), p.306-307

2003

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Bücher
(2)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(11)
Psychiatry
(11)
Humans
(10)
Schizophrenia
(9)
Female
(8)
Male
(8)
Psychosis
(8)
Adult
(6)
Adolescent
(5)
Young Adult
(5)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Prodromal Symptoms
(4)
Psychology. Psychoanalysis. Psychiatry
(4)
Psychopathology. Psychiatry
(4)
Schizophrenia - Diagnosis
(4)
Adult And Adolescent Clinical Studies
(3)
Clinical High Risk
(3)
Longitudinal Studies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Olanzapine and haloperidol in first episode psychosis: Two-year data

Neuropsychological status of subjects at high risk for a first episode of psychosis

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning

Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis

Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia

The Early Psychosis Screener (EPS): Item development and qualitative validation

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

Computational fluid dynamics modeling aiding surgical planning in a toddler with Parkes Weber syndrome

Factorial structure of the Scale of Prodromal Symptoms

0394 CLINICAL EFFECTIVENESS AND PREDICTORS OF TREATMENT NON-ADHERENCE: COMPARISON OF OLANZAPINE, QUETIAPINE, AND RISPERIDONE IN FIRST-EPISODE PSYCHOSIS

TC18C MRI OF BRAIN VOLUMES AT THE PRODROME AND FIRST EPISODE STAGES OF SCHIZOPHRENIA

P.3.c.054 Olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: effectiveness and factors influencing adherence to treatment

TC3A EXCESSIVE TOP-DOWN PERCEPTUAL PROCESSING AND REDUCED REAL-WORLD INVESTMENT EXHIBITED BY PRODROMAL PATIENTS PREDICT SUBSEQUENT CONVERSION TO SCHIZOPHRENIA

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

WC8B NEUROCOGNITIVE FUNCTIONING IN THE PRODROME TO PSYCHOSIS FROM THE NAPLS COLLABORATION

S.14.04 CATIE trial results

Investigation of olanzapine-associated weight gain in first episode subjects

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders

Clinical correlates of weight gain in first episode psychosis patients treated with olanzapine

Olanzapine versus placebo for prodromal symptoms

Suchergebnisse filtern